Pediatric orthopedic conditions in Charcot-Marie-Tooth disease: A literature review

Current Opinion in Pediatrics

Volumn 24, Issue 1, 2012, Pages 50-56

  Yagerman, Sarah E ^a   Cross, Michael B ^a   Green, Daniel W ^a   Scher, David M ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Charcot Marie Tooth; hip dysplasia; pediatric orthopedics; pes cavus; scoliosis

Indexed keywords

CLINICAL ASSESSMENT; FOOT SURGERY; HEREDITARY MOTOR SENSORY NEUROPATHY; HIP DYSPLASIA; HUMAN; ORTHOPEDIC SPECIALIST; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PATIENT CARE; PEDIATRIC SURGERY; PRIORITY JOURNAL; REVIEW; SCOLIOSIS; SPINE MALFORMATION;

ADOLESCENT; ANKLE; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; FOOT DEFORMITIES, ACQUIRED; HIP JOINT; HUMANS; MALE; MUSCLE WEAKNESS; SCOLIOSIS;

EID: 84856086397     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834e9051     Document Type: Review

References (42)

1. Amato AA, Barohn RJ. Peripheral Neuropathy. In: Longo DL, Fauci AS, Kasper DL, et al., eds. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2012. http://www.accessmedicine.com/content.aspx?aID= 9148461. [Accessed 22 November 2011]
2. Newman CJ, Walsh M, O'Sullivan R, et al. The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture 2007; 26:120-127. (Pubitemid 46629138)
3. Braathen GJ, Sand JC, Lobato A, et al. Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol 2011; 18:39-48.
4. Guyton GP. Current concepts review: orthopaedic aspects of Charcot-Marie-Tooth disease. Foot Ankle Int 2006; 27:1003-1010. An excellent review and description of the most classic presentations of CMT in the most common subtypes. (Pubitemid 44672487)
5. Banchs I, Casasnovas C, Alberti A, et al. Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol 2009; 2009:985415.
6. Burns J, Ryan MM, Ouvrier RA. Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 2009; 39:158-166.
7. Casasnovas C, Cano LM, Alberti A, et al. Charcot-Marie-Tooth disease. Foot Ankle Spec 2008; 1:350-354.
8. Barisic N, Claeys KG, Sirotkovic-Skerlev M, et al. Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann Hum Genet 2008; 72:416-441.
9. Burgunder JM, Schols L, Baets J, et al. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders. Eur J Neurol 2011; 18:207-217.
10. Aminoff MJ, Kerchner GA. Nervous System Disorders. In: McPhee SJ, Papadakis MA, Rabow MW, eds. CURRENT Medical Diagnosis Treatment 2012. New York: McGraw-Hill; 2012. http://www.accessmedicine.com/content. aspx?aID=12507. [Accessed 22 November 2011]
11. Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 2009; 8:654-667.
12. Berciano J, Garcia A, Calleja J, et al. Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication. Neuromuscul Disord 2000; 10:419-424. (Pubitemid 30433812)
13. Szigeti K, Nelis E, Lupski JR. Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies. Neuromolecular Med 2006; 8:243-254.
14. Isner JM, Hawley RJ, Weintraub AM, et al. Cardiac findings in Charcot-Marie-Tooth disease. A prospective study of 68 patients. Arch Intern Med 1979; 139:1161-1165. (Pubitemid 10143825)
15. Losito L, De Rinaldis M, Gennaro L, et al. Charcot-Marie-Tooth type 1a in a child with Long QT syndrome. Eur J Paediatr Neurol 2009; 13:459-462.
16. Tetzlaff JE, Schwendt I. Arrhythmia and Charcot-Marie-Tooth disease during anesthesia. Can J Anaesth 2000; 47:829.
17. Corrado G, Checcarelli N, Santarone M, et al. Left ventricular hypertrabeculation/ noncompaction with PMP22 duplication-based Charcot-Marie-Tooth disease type 1A. Cardiology 2006; 105:142-145.
18. Chaouch M, Allal Y, De Sandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord 2003; 13:60-67. (Pubitemid 35430141)
19. Guyton GP, Mann RA. The pathogenesis and surgical management of foot deformity in Charcot-Marie-Tooth disease. Foot Ankle Clin 2000; 5:317-326.
20. Mann RA, Missirian J. Pathophysiology of Charcot-Marie-Tooth disease. Clin Orthop Relat Res 1988; (234):221-228.
21. Nagai MK, Chan G, Guille JT, et al. Prevalence of Charcot-Marie-Tooth disease in patients who have bilateral cavovarus feet. J Pediatr Orthop 2006; 26:438-443. (Pubitemid 44384905)
22. Wines AP, Chen D, Lynch B, et al. Foot deformities in children with hereditary motor and sensory neuropathy. J Pediatr Orthop 2005; 25:241-244. (Pubitemid 40315446)
23. Rose KJ, Burns J, Wheeler DM, et al. Interventions for increasing ankle range of motion in patients with neuromuscular disease. Cochrane Database Syst Rev 2010:CD006973.
24. Sackley C, Disler PB, Turner-Stokes L, et al. Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev 2009:CD003908.
25. Burns J, Raymond J, Ouvrier R. Feasibility of foot and ankle strength training in childhood Charcot-Marie-Tooth disease. Neuromuscul Disord 2009; 19:818-821.
26. Burns J, Scheinberg A, Ryan MM, et al. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric Charcot-Marie-Tooth disease type 1A. Muscle Nerve 2010; 42:262-267.
27. Saltzman CL, el-Khoury GY. The hindfoot alignment view. Foot Ankle Int 1995; 16:572-576.
28. Mosca VS, Ragab AA, Stewart SL, Cooperman DR. Implications of subtalar joint anatomic variation in calcaneal lengthening osteotomy. J Pediatr Orthop 2003; 23:79-83. (Pubitemid 36015464)
29. Ward CM, Dolan LA, Bennett DL, et al. Long-term results of reconstruction for treatment of a flexible cavovarus foot in Charcot-Marie-Tooth disease. J Bone Joint Surg Am 2008; 90:2631-2642. This article evaluates and proposes the most efficacious method in terms of joint function for reconstructive surgeries for cavovarus foot in patients with CMT.
30. Wukich DK, Bowen JR. A long-termstudy of triple arthrodesis for correction of pes cavovarus in Charcot-Marie-Tooth disease. J Pediatr Orthop 1989; 9:433-437. (Pubitemid 19190377)
31. Saltzman CL, Fehrle MJ, Cooper RR, et al. Triple arthrodesis: twenty-five and forty-four-year average follow-up of the same patients. J Bone Joint Surg Am 1999; 81:1391-1402. (Pubitemid 29489472)
32. Smith CK. Vertebral deformities and other anomalies in Charcot-Marie-Tooth disease. Neurology 1958; 8:481-486.
33. Hensinger RN, MacEwen GD. Spinal deformity associated with heritable neurological conditions: spinal muscular atrophy, Friedreich's ataxia, familial dysautonomia, and Charcot-Marie-Tooth disease. J Bone Joint Surg Am 1976; 58:13-24.
34. Horacek O, Mazanec R, Morris CE, et al. Spinal deformities in hereditary motor and sensory neuropathy: a retrospective qualitative, quantitative, genotypical, and familial analysis of 175 patients. Spine (Phila Pa 1976) 2007; 32:2502-2508. This article is a retrospective study of 175 patients to determine the estimated incidence of spinal deformity in patients with CMT. (Pubitemid 350303699)
35. Kumar SJ, Marks HG, Bowen JR, et al. Hip dysplasia associated with Charcot-Marie-Tooth disease in the older child and adolescent. J Pediatr Orthop 1985; 5:511-514. (Pubitemid 15019314)
36. McGann R, Gurd A. The association between Charcot-Marie-Tooth disease and developmental dysplasia of the hip. Orthopedics 2002; 25:337-339. (Pubitemid 34284805)
37. Ushiyama T, Tanaka C, Kawasaski T, et al. Hip dysplasia in Charcot-Marie-Tooth disease: report of a family. J Orthop Sci 2003; 8:610-612. (Pubitemid 37012079)
38. Walker JL, Nelson KR, Heavilon JA, et al. Hip abnormalities in children with Charcot-Marie-Tooth disease. J Pediatr Orthop 1994; 14:54-59. (Pubitemid 24003042)
39. Chan G, Bowen JR, Kumar SJ. Evaluation and treatment of hip dysplasia in Charcot-Marie-Tooth disease. Orthop Clin North Am 2006; 37:203-209; vii.
40. Ramdharry GM, Day BL, Reilly MM, et al. Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease. Muscle Nerve 2009; 40:103-111.
41. Bamford NS, White KK, Robinett SA, et al. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A. Dev Med Child Neurol 2009; 51:408-411.
42. Canavese F, Sussman MD. Strategies of hip management in neuromuscular disorders: duchenne muscular dystrophy, spinal muscular atrophy, Charcot-Marie-Tooth disease and arthrogryposis multiplex congenita. Hip Int 2009; 19 (Suppl 6):S46-S52.